# A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD

> **NCT06557369** · NA · RECRUITING · sponsor: **Oculox Technologies SA** · enrollment: 30 (estimated)

## Conditions studied

- Intermediate AMD

## Interventions

- **DEVICE:** reSEES

## Key facts

- **NCT ID:** NCT06557369
- **Lead sponsor:** Oculox Technologies SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06557369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06557369, "A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06557369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*